Seeking Alpha EN

Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity

Mar 10, 2026 &03121010202631; 13:12 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

→

Neutral impact

Sentiment score: 0/100

Moderate impact Immediate effect (hours)

WHAT THIS MEANS

Creatd divests its remaining stake in Fly Flyte to Catheter Precision for approximately $12 million in cash and equity, reducing exposure to the medical device subsidiary. This transaction allows Creatd to monetize its investment and improve liquidity while Catheter Precision gains full control of the business.

AI CONFIDENCE

65% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

CREATD

CREATDStock

Expected to rise

Divestiture generates $12M in cash and equity, improving balance sheet and liquidity position

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Monitor Creatd's cash deployment strategy and balance sheet metrics post-transaction. The $12M capital injection could support operations or debt reduction; watch for management guidance on capital allocation priorities.

KEY SIGNALS

Asset monetizationLiquidity improvementPortfolio restructuringStake reductionCash inflow

SECTORS INVOLVED

HealthcareMedical DevicesBiotechnology

Analysis generated on Mar 11, 2026 at 02:22 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity

RELATED INTELLIGENCE